ImmunoGen (NASDAQ:IMGN) Earns Hold Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of ImmunoGen (NASDAQ:IMGN – Free Report) in a research report sent to investors on Thursday. The firm issued a hold rating on the biotechnology company’s stock. Other research analysts also recently issued research reports about the stock. Jefferies Financial Group restated a hold rating and set a $31.00 price objective […]
More Stories
Trip.com Group (NASDAQ:TCOM) Given New $80.00 Price Target at Benchmark
Trip.com Group (NASDAQ:TCOM – Free Report) had its price target boosted by Benchmark from $72.00 to $80.00 in a research...
BMO Capital Markets Lowers Ascot Resources (TSE:AOT) Price Target to C$0.75
Ascot Resources (TSE:AOT – Free Report) had its price objective trimmed by BMO Capital Markets from C$1.25 to C$0.75 in...
Trevena (NASDAQ:TRVN) Coverage Initiated by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a research report report published on Tuesday. The...
Aclaris Therapeutics (NASDAQ:ACRS) Upgraded by BTIG Research to Buy Rating
BTIG Research upgraded shares of Aclaris Therapeutics (NASDAQ:ACRS – Free Report) from a neutral rating to a buy rating in...
Siemens Aktiengesellschaft (OTCMKTS:SIEGY) Rating Lowered to Neutral at Bank of America
Bank of America cut shares of Siemens Aktiengesellschaft (OTCMKTS:SIEGY – Free Report) from a buy rating to a neutral rating...
Origin Agritech (NASDAQ:SEED) Earns Hold Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of Origin Agritech (NASDAQ:SEED – Free Report) in a research note published on Tuesday. The...